GILEAD SCIENCES INC's ticker is and the CUSIP is 375558AN3. A total of 33 filers reported holding GILEAD SCIENCES INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2014 | $40,644,000 | – | 573,600 | – | 2.35% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fore Research & Management, LP | 106,845,000 | $297,627,000 | 18.70% |
ANGELO GORDON & CO., L.P. | 64,500,000 | $179,592,000 | 11.62% |
Amida Capital Management II, LLC | 8,000,000 | $22,275,000 | 8.53% |
DAVIDSON KEMPNER CAPITAL MANAGEMENT LLC | 85,000,000 | $236,515,000 | 7.84% |
Orchard Hill Capital Management LP | 50,977,000 | $141,896,000 | 7.12% |
HBK INVESTMENTS L P | 169,281,000 | $470,799,000 | 6.89% |
Man Investments (CH) AG | 4,600,000 | $12,783,000 | 5.83% |
MACKAY SHIELDS LLC | 31,008,000 | $86,370,000 | 4.64% |
INCOME RESEARCH & MANAGEMENT | 6,661 | $18,547,000 | 3.13% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 45,150,000 | $125,729,000,000 | 2.62% |